Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
Xiaolei Lian(Children's Cancer Therapy Development Institute), Noah Berlow(Health First)
Cited by 40
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|136
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
|BMC Cancer|2019|19
BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA
|Neuro-Oncology|2015|4
Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma
|Molecular Case Studies|2021|0